Your browser doesn't support javascript.
loading
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.
Frezza, Anna M; Ravi, Vinod; Lo Vullo, Salvatore; Vincenzi, Bruno; Tolomeo, Francesco; Chen, Tom Wei-Wu; Teterycz, Pawel; Baldi, Giacomo G; Italiano, Antoine; Penel, Nicolas; Brunello, Antonella; Duffaud, Florance; Hindi, Nadia; Iwata, Shintaro; Smrke, Alannah; Fedenko, Alexander; Gelderblom, Hans; Van Der Graaf, Winette; Vozy, Aurore; Connolly, Elizabeth; Grassi, Massimiliano; Benjamin, Robert S; Broto, Javier-Martin; Grignani, Giovanni; Jones, Robin L; Kawai, Akira; Tysarowski, Andrzej; Mariani, Luigi; Casali, Paolo G; Stacchiotti, Silvia.
Afiliação
  • Frezza AM; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Italy.
  • Lo Vullo S; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Vincenzi B; Department of Medical Oncology, Università Campus Bio-Medico di Roma, Roma, Italy.
  • Tolomeo F; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Chen TW; Department of Oncology, National Taiwan University Hospital and Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Teterycz P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Baldi GG; Department of Medical Oncology, Nuovo Ospedale "S.Stefano", Prato, Italy.
  • Italiano A; Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France.
  • Penel N; Medical Oncology Department, Centre Oscar Lambret, Lille, France.
  • Brunello A; Medical School, Lille University, Lille, France.
  • Duffaud F; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Hindi N; Department of Medical Oncology, Medical Oncology, La Timone University Hospital, Aix-Marseille Université (AMU, Marseille, France.
  • Iwata S; Medical Oncology Department, University Hospital Virgen del Rocio, and Institute of Biomedicine, Sevilla, Spain.
  • Smrke A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Fedenko A; Sarcoma Unit, Royal Marsden NHS Foundation Trust/ Institute of Cancer Research, Chelsea, London, United Kingdom.
  • Gelderblom H; Division of Medical Oncology, P.A. Herzen Cancer Research Institute, Moscow, Russian Federation.
  • Van Der Graaf W; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Vozy A; Department of Medical Oncology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.
  • Connolly E; Department of Medical Oncology, Pitié Salpétrière Hospital, Paris, France.
  • Grassi M; Department Of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia.
  • Benjamin RS; Medical Oncology Unit 1, Ospedale Policlinico San Martino IRCCS, University of Genoa, Genoa, Italy.
  • Broto JM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Italy.
  • Grignani G; Medical Oncology Department, University Hospital Virgen del Rocio, and Institute of Biomedicine, Sevilla, Spain.
  • Jones RL; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Torino, Italy.
  • Kawai A; Sarcoma Unit, Royal Marsden NHS Foundation Trust/ Institute of Cancer Research, Chelsea, London, United Kingdom.
  • Tysarowski A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Mariani L; Pathology department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Casali PG; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Stacchiotti S; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
Cancer Med ; 10(8): 2645-2659, 2021 04.
Article em En | MEDLINE | ID: mdl-33713582
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Hemangioendotelioma Epitelioide Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Hemangioendotelioma Epitelioide Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article